Esperion Therapeutics, Inc.

VOYA INVESTMENT MANAGEMENT LLC ESPR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

40,523

Value ($000)

150

Weight

0.0%

2019 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	150	0.0%	40,523	12/31/2025
2025 Q3	10/9/2025	101	0.0%	37,996	9/30/2025
2025 Q2	8/14/2025	56	0.0%	56,580	6/30/2025
2025 Q1	5/15/2025	76	0.0%	52,766	3/31/2025
2024 Q4	5/2/2025	129	0.0%	58,737	12/31/2024
2024 Q3	2/7/2025	104	0.0%	63,142	9/30/2024
2024 Q2	2/7/2025	140	0.0%	63,029	6/30/2024
2023 Q1	2/7/2025	45	0.0%	28,043	3/31/2023
2022 Q4	2/7/2025	175	0.0%	28,043	12/31/2022
2022 Q3	2/7/2025	178	0.0%	26,529	9/30/2022
2022 Q2	8/15/2022	155	0.0%	24,387	6/30/2022
2022 Q1	5/16/2022	220	0.0%	47,435	3/31/2022
2021 Q3	11/15/2021	128	0.0%	10,593	9/30/2021
2021 Q2	8/16/2021	224	0.0%	10,593	6/30/2021
2021 Q1	5/17/2021	330	0.0%	11,780	3/31/2021
2020 Q4	2/16/2021	290	0.0%	11,156	12/31/2020
2020 Q3	11/16/2020	331	0.0%	8,909	9/30/2020
2020 Q2	8/14/2020	457	0.0%	8,909	6/30/2020
2020 Q1	5/15/2020	398	0.0%	12,609	3/31/2020
2019 Q4	2/14/2020	731	0.0%	12,262	12/31/2019